CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use the original agreement and policy sources for this record to identify the exact clause, its legal source, and the stated consequence. Preserve those facts before reaching a conclusion about a particular provider or condition.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
PENNSYLVANIA · CONTRACT FOR CARE · DOCUMENT RECORD
SEPA Pain & Spine: document versus identified state authority
Document: Long-Term Controlled Substance Therapy Agreement for Chronic Pain. Version: Printed update: May 2019.
Status: Publicly linked older revision; present office use unconfirmed.
The current patient-resources page links this two-page form. Its printed May 2019 revision predates Act 112. Current signed version, addenda and office-by-office implementation are unconfirmed.
Read the complete original public document · Find the listed offices
Source-located terms
The table summarizes the clauses. Page references use PDF viewer pages, with clause numbers where printed. Follow the source link for the complete exact wording. Classifications are comparisons with the authority identified below, not determinations of enforceability or proof of patient outcomes.
| Source location | Document requirement or consequence — summary | Classification |
|---|---|---|
| PDF p.1, clause 1 | One SEPA prescriber unless an exception is specifically authorized. | Institution-specific policy |
| PDF p.1, clause 2 | Use one pharmacy where possible; notify SEPA of changes. | Institution-specific policy |
| PDF p.1, clause 3 | Report new medicines, conditions and adverse effects within a week. | Institution-specific policy |
| PDF p.1, clause 4 | Permit treatment discussions with dispensing pharmacists and other treating professionals. | Unresolved / legal review |
| PDF p.1, clause 5 | No illegal substances, including marijuana; no sharing; other controlled prescriptions need approval. | Unresolved / legal review |
| PDF p.2, clause 6 | Renewals require scheduled visits; no evening or weekend refills. | Institution-specific policy |
| PDF p.2, clause 7 | Acknowledges withdrawal risk if these drugs are stopped abruptly. | Guidance / template only |
| PDF p.2, clause 8 | Cooperate with unannounced urine, saliva or serum screens; unauthorized substances may end care. | Broader than identified authority |
| PDF p.2, clause 9 | Bring original medication containers to every visit. | Institution-specific policy |
| PDF p.2, clause 10 | Keep medication away from children and people intolerant to it. | Authorized / contemplated; discretionary |
| PDF p.2, clause 11 | Lost or damaged medication may go unreplaced; theft exception requires a police report. | Institution-specific policy |
| PDF p.2, clause 12 | Early prescriptions for travel are discretionary, with delayed-fill instructions. | Institution-specific policy |
| PDF p.2, clause 13 | Waives prescription-related confidentiality when law enforcement approaches SEPA; legal scope unresolved. | Unresolved / legal review |
| PDF p.2, clause 14 | Nonadherence may end controlled-substance therapy or lead to specialty assessment. | Required subject / implementation discretionary |
| PDF p.2, clause 15 | Continued prescribing depends on evidence of benefit from the treatment trial. | Authorized / contemplated; discretionary |
| PDF p.2, clause 16 | Acknowledges treatment risks and potential benefits. | Required subject / implementation discretionary |
What the government requirement establishes
35 Pa.C.S. §52B02 requires covered treatment agreements to address goals, medically necessary targeted testing consent, prescribed use, no sharing, other controlled substances, reasons for changing or stopping therapy and disposal. Subsections (c)–(e) address testing and documented exceptions. Those required subjects do not make every facility-specific deadline, fee, restriction or discharge outcome mandatory.
28 Pa. Code §26.4 addresses testing, alternative testing for medical necessity, agreement termination and continuity of care. DOH implementation guidance says Act 112 does not require a particular pharmacy or targeted blood testing. Specific program, payer, privacy, professional or consent authorities may require further review; none are inferred from a form’s introductory assertion that laws apply.
Additional public policy documents
The May 2019 financial form, p.1 describes personal payment if insurance denies a claim, appeal rights and a choice to decline or discontinue SEPA services. Its “ABN” label does not establish that it satisfies a particular payer’s requirements.
The separate procedure-consent and court record documents venue-selection terms. The current public consent names Montgomery County; the 2025 opinion quotes a different Bucks County version. These are distinct documents.
Refusal, inability to comply and current use
The tables report consequences expressly described by the source, including possible prescribing cessation, medication gaps, rescheduling or dismissal where stated. They do not establish what happened to a particular patient. Current signed copies, exception policies, accommodations, taper/transfer procedures and office-specific practice confirmation remain needed. Unresolved privacy, cannabis, payment or legal-scope questions remain for legal review.
Practice: correct this record or supply the current version
Patient or practice: submit a contract, policy or newer version
Research date: October 12, 2026. Methodology and version history.